DC STEM Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on DC STEM Digest.

Press releases published on April 27, 2026

Apr. 27, 2026

NRB Files FCC Complaint Over Jimmy Kimmel Live! Monologue

Indeterminate EIN Presswire

Apr. 27, 2026

Data Center Pioneers Byrne Murphy and William Conway Return to Nordics to Develop 500+ MWs of Data Center Infrastructure

Indeterminate EIN Presswire

Apr. 27, 2026

Steve Suarez & Rebecca Kramer Explain Cyber Resilience & the Quantum Threat in the CAIO Connect Podcast with Sanjay Puri

Indeterminate EIN Presswire

Apr. 27, 2026

Luis Antonio Diaz Discusses Data Sovereignty & Trust in the Age of Automation on RegulatingAI Podcast with Sanjay Puri

Indeterminate EIN Presswire

Apr. 27, 2026

Educational Webinar: Unlocking the Potential of PSMA Therapy, A Next‑Generation Portfolio Approach

Indeterminate GlobeNewswire

Apr. 27, 2026

Smart Sellers Academy Launches Multi‑Channel Expansion to Power the Next Generation of Digital Brands

Indeterminate GlobeNewswire

Apr. 27, 2026

Crypto News: AlphaPepe Presale Crosses $980k Raised as Ethereum Price Prediction Targets $7,500 Amid Massive ETF Inflows

Indeterminate GlobeNewswire

Apr. 27, 2026

New Peer‑Reviewed Study Reveals Actionable Immune–Microenvironment Target in Brain Metastasis; Medicinova Advances Clinical Translation

Indeterminate GlobeNewswire

Apr. 27, 2026

Anuma launches private AI with one memory across every leading model

Indeterminate GlobeNewswire

Apr. 27, 2026

Biomea Fusion Announces Positive 52-Week Results from Phase 2 COVALENT-112 Trial in Type 1 Diabetes Showing C-Peptide Improvement and Durability Following 12-Weeks of Icovamenib Treatment

Indeterminate GlobeNewswire

Apr. 27, 2026

Taysha Gene Therapies to Present New Preclinical Data Supporting Construct Design of TSHA-102 for Rett Syndrome at the ASGCT 2026 Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

Lexeo Therapeutics Announces Multiple Presentations at the 29th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

Crinetics Pharmaceuticals Announces the European Commission Approval of PALSONIFY® (Paltusotine) for the Treatment of Acromegaly in Adults

Indeterminate GlobeNewswire

Apr. 27, 2026

ElevateBio to Present Nine Abstracts Showcasing Advancements Across its Gene Editing Platform at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

Arbor Biotechnologies to Present Expansion of CNS Editing Platform Capabilities at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

Canada's Newcomer Children Have an Academic Integration Gap. A Community-Owned Ontario Startup Just Partnered With Three School Boards to Close It

Indeterminate GlobeNewswire

Apr. 27, 2026

Cabaletta Bio Announces Multiple Upcoming Presentations, Including Data on Rese-cel without Preconditioning and Rese-cel with Automated Manufacturing, at the ASGCT 2026 Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

Tessera Therapeutics to Present New Preclinical Data Supporting In Vivo Program in Sickle Cell Disease and Advancements in In Vivo CAR-T Applications at the American Society of Gene and Cell Therapy 29th Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

Aclaris Therapeutics to Provide Clinical Update on Key Biologic and Oral Inhibitor Programs on April 28, 2026

Indeterminate GlobeNewswire

Apr. 27, 2026

Dyne Therapeutics Announces Upcoming Presentation Highlighting Robust CNS Activity in Nonhuman Primates with its FORCE™ Platform at 2026 ASGCT Annual Meeting

Indeterminate GlobeNewswire